Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 12.05
-0.12 (-0.99%)
Sep 10, 2025, 3:30 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 1.57 billion as of September 10, 2025. Its market cap has decreased by -24.46% in one year.
Market Cap
1.57B
Enterprise Value
1.68B
Revenue
1.05B
Ranking
n/a
PE Ratio
395.39
Stock Price
12.05
Market Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 1.57B, an increase of 448.49%. That is a compound annual growth rate of 23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 1.59B | -24.94% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | 738.76M | 115.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,793.35B |
| Divi's Laboratories | 1,600.11B |
| Cipla | 1,254.77B |
| Apollo Hospitals Enterprise | 1,119.58B |
| Mankind Pharma | 1,064.67B |
| Zydus Lifesciences | 1,015.94B |
| Fortis Healthcare | 711.85B |
| Alkem Laboratories | 637.64B |